Mixed hepatocellular carcinoma and cholangiocarcinoma in liver transplantation: Prognostic factors for outcomes in Korea-Japan multicenter study

Mixed hepatocellular carcinoma and cholangiocarcinoma in liver transplantation: Prognostic factors for outcomes in Korea-Japan multicenter study - Mixed hepatocellular carcinoma and cholangiocarcinoma in liver transplantation: Prognostic factors for outcomes in Korea-Japan multicenter study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042980

Enrollment

Registered

2021-01-20

Start date

2020-12-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mixed hepatocellular carcinoma and cholangiocarcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pathologically proven mixed HCC-CC after liver transplantation. Liver transplantation was performed between January 2000 and December 2018.

Exclusion criteria

Exclusion criteria: Pathologically proven HCC or intrahepatic CCC after liver transplantation.

Design outcomes

Primary

Measure	Time frame
Risk factors for tumor recurrence and patient survival	—

Secondary

Measure	Time frame
Prediction of patients with mixed HCC-CC after liver transplantation	—

Countries

Japan,Asia(except Japan)

Contacts

Public ContactTomoharu Yoshizumi

Kyushu University Department of Surgery and Science

yoshizumi.tomoharu.717@m.kyushu-u.ac.jp092-642-5466

Outcome results